Clear cell carcinoma of the ovary: a clinical and molecular perspective
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clear cell carcinoma of the ovary: a clinical and molecular perspective
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Volume -, Issue -, Pages ijgc-2020-001656
Publisher
BMJ
Online
2020-09-19
DOI
10.1136/ijgc-2020-001656
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study
- (2020) Marjolein Hermens et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- The DNA cytosine deaminase APOBEC3B is a molecular determinant of platinum responsiveness in clear cell ovarian cancer
- (2020) Reuben S. Harris et al. CLINICAL CANCER RESEARCH
- Adjuvant chemotherapy vs. observation in stage I clear cell ovarian carcinoma: A systematic review and meta-analysis
- (2020) Giorgio Bogani et al. GYNECOLOGIC ONCOLOGY
- Fertility sparing surgery for patients with FIGO stage I clear cell ovarian carcinoma: a database analysis and systematic review of the literature
- (2020) Dimitrios Nasioudis et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
- (2019) Mitsutake Yano et al. Scientific Reports
- Radiotherapy for isolated recurrent epithelial ovarian cancer: A single institutional experience
- (2019) Naoko Komura et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Genome-wide interrogation of human cancers identifies EGLN1 dependency in clear cell ovarian cancers
- (2019) Colles Price et al. CANCER RESEARCH
- Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse
- (2019) Robert L. Hollis et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†
- (2019) N Colombo et al. ANNALS OF ONCOLOGY
- Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype
- (2019) Masataka Takenaka et al. CLINICAL CANCER RESEARCH
- HDAC6 inhibition synergizes with anti-PD-L1 therapy in ARID1A-inactivated ovarian cancer.
- (2019) Takeshi Fukumoto et al. CANCER RESEARCH
- Patterns of recurrence and impact on survival in patients with clear cell ovarian carcinoma
- (2019) Liat Hogen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clinical Characteristics of Clear Cell Ovarian Cancer: A Retrospective Multicenter Experience of 308 Patients in South Korea
- (2019) Hee Yeon Lee et al. Cancer Research and Treatment
- Evolving Concepts in the Management of Newly Diagnosed Epithelial Ovarian Cancer
- (2019) Charlie Gourley et al. JOURNAL OF CLINICAL ONCOLOGY
- Germline and somatic mutations of homologous recombination-associated genes in Japanese ovarian cancer patients
- (2019) Kentaro Sugino et al. Scientific Reports
- Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma
- (2019) Takafumi Kuroda et al. GYNECOLOGIC ONCOLOGY
- Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes
- (2019) Tuan Zea Tan et al. EBioMedicine
- Uncommon Human Telomerase Reverse Transcriptase Promoter Mutations Are Associated With Poor Survival in Ovarian Clear Cell Carcinoma
- (2018) Kyoko Nishikimi et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies
- (2018) Joseph J. Caumanns et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma
- (2018) Joseph J. Caumanns et al. CLINICAL CANCER RESEARCH
- Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing
- (2018) Se Ik Kim et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)
- (2018) John K. Chan et al. GYNECOLOGIC ONCOLOGY
- Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics
- (2018) Jaime Prat et al. HUMAN PATHOLOGY
- Histotype classification of ovarian carcinoma: A comparison of approaches
- (2018) Lauren C. Peres et al. GYNECOLOGIC ONCOLOGY
- Involved-field radiation therapy for recurrent ovarian cancer: Results of a multi-institutional prospective phase II trial
- (2018) Jee Suk Chang et al. GYNECOLOGIC ONCOLOGY
- Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing
- (2017) Yusuke Shibuya et al. GENES CHROMOSOMES & CANCER
- An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience
- (2017) Kate E. Oliver et al. GYNECOLOGIC ONCOLOGY
- Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis
- (2017) Yoshiaki Maru et al. GYNECOLOGIC ONCOLOGY
- Associations between residual disease and survival in epithelial ovarian cancer by histologic type
- (2017) Alexander Melamed et al. GYNECOLOGIC ONCOLOGY
- Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma – A multi-institutional cohort
- (2017) Emily N. Prendergast et al. GYNECOLOGIC ONCOLOGY
- Informing women with endometriosis about ovarian cancer risk
- (2017) Marina Kvaskoff et al. LANCET
- ARID1A-mutated ovarian cancers depend on HDAC6 activity
- (2017) Benjamin G. Bitler et al. NATURE CELL BIOLOGY
- Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
- (2017) Yi Kan Wang et al. NATURE GENETICS
- Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma
- (2017) Nicolai Skovbjerg Arildsen et al. Frontiers in Oncology
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- The effect of adjuvant radiation on survival in early stage clear cell ovarian carcinoma
- (2016) Liat Hogen et al. GYNECOLOGIC ONCOLOGY
- BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer
- (2016) John P. Stamp et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Molecular Profiling of Clear Cell Ovarian Cancers
- (2016) Michael L. Friedlander et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Fertility-sparing surgery for early stage epithelial ovarian cancer
- (2016) Toyomi Satoh et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium
- (2016) Nicolas Wentzensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial
- (2016) Toru Sugiyama et al. JOURNAL OF CLINICAL ONCOLOGY
- Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
- (2016) Seiji Mabuchi et al. Journal of Gynecologic Oncology
- Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Robert J. Morgan et al. Journal of the National Comprehensive Cancer Network
- Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma
- (2016) Hisham Abou-Taleb et al. Oncotarget
- Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma With Clear Cell Change, and Clear Cell Carcinoma
- (2015) Diana Lim et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
- (2015) Junzo Hamanishi et al. JOURNAL OF CLINICAL ONCOLOGY
- Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden
- (2015) Michael S Anglesio et al. JOURNAL OF PATHOLOGY
- Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
- (2015) Benjamin G Bitler et al. NATURE MEDICINE
- Coexistent ARID1A–PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling
- (2015) Ronald L. Chandler et al. Nature Communications
- APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity
- (2015) C. Swanton et al. Cancer Discovery
- Somatic Copy Number Alterations Associated with Japanese or Endometriosis in Ovarian Clear Cell Adenocarcinoma
- (2015) Aikou Okamoto et al. PLoS One
- Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas
- (2015) Yuriko Uehara et al. PLoS One
- Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary
- (2014) Aikou Okamoto et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation
- (2014) Hsien-Neng Huang et al. MODERN PATHOLOGY
- Involved-field radiation therapy for locoregionally recurrent ovarian cancer
- (2013) Aaron P. Brown et al. GYNECOLOGIC ONCOLOGY
- Prevalence and Prognostic Impact of Lymphadenectomy and Lymph Node Metastasis in Clinically Early-Stage Ovarian Clear Cell Carcinoma
- (2013) Haider Mahdi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas
- (2013) Eleftherios Samartzis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan
- (2013) Ying-Cheng Chiang et al. Journal of Gynecologic Oncology
- Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy
- (2013) Ren-Chin Wu et al. JOURNAL OF PATHOLOGY
- Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial
- (2013) Noriyuki Katsumata et al. LANCET ONCOLOGY
- Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma
- (2013) Hsien-Neng Huang et al. MODERN PATHOLOGY
- Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis
- (2013) Yoriko Yamashita et al. PLoS One
- Clear cell carcinoma of the ovary: A review of the literature
- (2012) Marcela G. del Carmen et al. GYNECOLOGIC ONCOLOGY
- Adjuvant Chemotherapy for Stage I Clear Cell Carcinoma of the Ovary
- (2012) Toshio Takada et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Adjuvant Chemotherapy for Stage I Ovarian Clear Cell Carcinoma
- (2012) Mika Mizuno et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Postrecurrent Oncologic Outcome of Patients With Ovarian Clear Cell Carcinoma
- (2012) Hiroaki Kajiyama et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Low-Stage Ovarian Clear Cell Carcinoma: Population-Based Outcomes in British Columbia, Canada, With Evidence for a Survival Benefit As a Result of Irradiation
- (2012) Paul J. Hoskins et al. JOURNAL OF CLINICAL ONCOLOGY
- Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?
- (2012) Masashi Takano et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Histology-specific long-term trends in the incidence of ovarian cancer and borderline tumor in Japanese females: A population-based study from 1983 to 2007 in Niigata
- (2012) Tetsuro Yahata et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
- (2012) Celeste Leigh Pearce et al. LANCET ONCOLOGY
- Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma
- (2011) Mohammed Tanjimur Rahman et al. CANCER
- Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
- (2011) David S.P. Tan et al. CLINICAL CANCER RESEARCH
- Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: A meta-analysis
- (2011) Yoo-Young Lee et al. GYNECOLOGIC ONCOLOGY
- Lymph node metastasis in stages I and II ovarian cancer: A review
- (2011) M. Kleppe et al. GYNECOLOGIC ONCOLOGY
- Fertility-sparing surgery in patients with clear-cell carcinoma of the ovary: Is it possible?
- (2011) H. Kajiyama et al. HUMAN REPRODUCTION
- Salvage chemotherapy for recurrent or persistent clear cell carcinoma of the ovary: a single-institution experience for a series of 20 patients
- (2011) Kiyoshi Yoshino et al. International Journal of Clinical Oncology
- Surgical and Medical Treatment of Clear Cell Ovarian Cancer
- (2011) Francescapaola Magazzino et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas
- (2011) Melissa K McConechy et al. JOURNAL OF PATHOLOGY
- Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient
- (2011) Sohei Yamamoto et al. MODERN PATHOLOGY
- Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations
- (2011) Sohei Yamamoto et al. MODERN PATHOLOGY
- DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma
- (2010) K. T. Kuo et al. CLINICAL CANCER RESEARCH
- The Impact of Complete Surgical Staging Upon Survival in Early-Stage Ovarian Clear Cell Carcinoma
- (2010) Masashi Takano et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clear Cell Carcinoma Compared to Serous Carcinoma in Early Ovarian Cancer
- (2010) P. J. Timmers et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Randomized Phase II Trial of Paclitaxel Plus Carboplatin Therapy Versus Irinotecan Plus Cisplatin Therapy as First-Line Chemotherapy for Clear Cell Adenocarcinoma of the Ovary
- (2010) Satoshi Takakura et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
- (2010) Helen J. Mackay et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
- (2010) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
- (2009) Kuan-Ting Kuo et al. AMERICAN JOURNAL OF PATHOLOGY
- When ‘never-events’ occur despite adherence to clinical guidelines: The case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes
- (2009) Linda R. Duska et al. GYNECOLOGIC ONCOLOGY
- Tumor type and substage predict survival in stage I and II ovarian carcinoma: Insights and implications
- (2009) Martin Köbel et al. GYNECOLOGIC ONCOLOGY
- Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients?
- (2008) S. Suzuki et al. ANNALS OF ONCOLOGY
- Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress
- (2008) K. Yamaguchi et al. CLINICAL CANCER RESEARCH
- Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers
- (2008) John K. Chan et al. GYNECOLOGIC ONCOLOGY
- Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study
- (2008) M. TAKANO et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer
- (2007) Eric L. Eisenhauer et al. GYNECOLOGIC ONCOLOGY
- Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
- (2007) William E. Winter et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started